Kao’s Laurier Launches New Brand Communication Initiative across Asia: Strengthening Global Integration as a Core Brand in Kao’s Asian Business Business Wire Starting on International Women’s Day, March 8, Kao Corporation (TOKYO:4452) will launch new brand communication campaign in nine Asian countries and regions for its feminine sanitary product brand, Laurier, which is the core of its Asian business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303996141/en/ Laurier aims to help create more supportive [...]
Morningstar Sustainalytics: Institutional Investors Signal Rising Demand for ESG Data Integration Amid Market Maturity Business Wire New global survey shows ESG and climate data moving from optional add-ons to core components of investment workflows.
New Betterworks Study Finds Almost 50% of Employees Are Not Comfortable Using AI, Challenging CHROs to Close the AI ROI Gap Business Wire Betterworks research shows that AI success hinges on performance enablement, not just on technology adoption.
New Study from Icertis and World Commerce & Contracting Dispels AI Disillusionment Myth February 26, 2026 Fourth Annual AI Survey Reveals Contract Value as Strategic Driver
Kolibri Global Energy Inc. Announces Issuance of Inaugural Sustainability Report February 26, 2026 Kolibri Global Energy Inc. (the “Company” or “Kolibri”) (TSX: KEI, NASDAQ: KGEI) is announcing that it has released its first Sustainability Report, which is available on the Company’s website at www.kolibrienergy.com under the “Investor” section. Kolibri’s report provides relevant information about our sustainability Environmental, Social and Governance (“ESG”) initiatives, practices, and related key performance indicators. [...]
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday February 16, 2026 A new post-hoc analysis from the LIBERTY studies, presented at ECCO 2026, demonstrated that initiating subcutaneous (SC) infliximab (Remsima™ SC) after a treatment interruption following intravenous (IV) infliximab induction helps patients with Crohn’s disease (CD) and ulcerative colitis (UC) recapture and maintain disease control1 The results demonstrated that SC infliximab provides an effective and safe option to regain clinical control after a planned or unplanned treatment interruption More than a total of 30 accepted abstracts including one oral and one digital oral presentation and eight posters, reinforce Celltrion’s commitment to inflammatory bowel disease (IBD) research aimed at enhancing patient outcomes
European Enterprises Adopt Robust Sustainability Practices February 12, 2026 Regulatory pressure, energy transformation drive companies toward integrated digital solutions spanning multiple enterprise functions, ISG Provider Lens® report says
North Highland Named in Financial Times 2026 UK Leading Management Consultants Report February 12, 2026 Firm recognised for sixth consecutive year by clients and peers with rankings across 10 industries and capabilities
New LRN Research Reveals Shifts in the Future of Global Ethics and Compliance Programs February 10, 2026 81% of respondents report their organization responded well to the global, economic, and social challenges of the past few years, but performance gaps remain
Love, Actually… Comes With a Back-Up Plan: 30m Brits Saving for a Break-Up February 10, 2026 Brits over 25 hold more than £140bn in hidden break-up funds More than 17 million people (31%) are hiding a savings account from their partner An estimated 23 million adults (43%) are actively adding to their ‘independence funds’